Live Breaking News & Updates on Pharmaceuticals Stock Down|Page 6
Stay updated with breaking news from Pharmaceuticals stock down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Get Free Report) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totalling 191,500 shares, a growth of 441.0% from the April 30th total of 35,400 shares. Based on an average daily trading volume, of 185,700 shares, the days-to-cover […] ....
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) shares reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $36.44 and last traded at $36.44, with a volume of 220851 shares traded. The stock had previously closed at $37.64. Analyst Ratings Changes Several equities analysts have recently weighed […] ....
StockNews.com started coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research note released on Saturday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Stock Down 4.5 % Shares of NASDAQ:TTNP opened at $6.42 on Friday. Titan Pharmaceuticals has a 12 month low of $5.00 […] ....
3Chopt Investment Partners LLC acquired a new position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the 4th quarter, HoldingsChannel reports. The fund acquired 599 shares of the biopharmaceutical company’s stock, valued at approximately $526,000. Several other institutional investors also recently bought and sold shares of the company. Eudaimonia Advisors LLC boosted its stake […] ....
AIGH Capital Management LLC raised its holdings in shares of scPharmaceuticals Inc. (NASDAQ:SCPH – Free Report) by 40.8% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 3,106,795 shares of the company’s stock after acquiring an additional 899,786 shares during the quarter. scPharmaceuticals accounts for about 7.7% of AIGH Capital Management LLC’s investment portfolio, […] ....